← Previous Post: | Next Post:


Tales from the Crypt, and a Limerick.

Forest Labs budgeted $100,000 for ghostwriting articles about its antidepressant Lexapro. The news came in a copy of Forest’s 2004 Lexapro marketing plan, unveiled by the Senate’s Special Committee on Aging.  [Forest] budgeted $100,000, including “honoraria” for authors, for articles that would appear in medical journals, consumer publications, and on the internet.

… The document will doubtless be of interest to federal prosecutors, who in February sued Forest for allegedly promoting its anti-depressants for pediatric use without FDA approval, and paying kickbacks to doctors to encourage prescriptions. The complaint also alleges that the company hid a negative study that later was used by the FDA in a decision to give both drugs black box warnings.

The document also indicates that Forest expected to put Emory University on its payroll.



Our anti-depressants are rife.
We give them to you and your wife.
With no ifs or maybes
We give them to babies
And make them pill-poppers for life.

Margaret Soltan, September 5, 2009 8:02AM
Posted in: ghost writing, limericks

Trackback URL for this post:

3 Responses to “Tales from the Crypt, and a Limerick.”

  1. Digger Says:

    That snippet from the marketing plan is extremely eye-opening.

  2. Margaret Soltan Says:

    Digger: It is. I tried to enlarge it, but I couldn’t figure out how to. Sorry to make my readers squint.

  3. University Diaries » If CEOs who condone ghostwriting are in trouble now… Says:

    […] Background here. […]

Comment on this Entry

Latest UD posts at IHE